Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Similar Items

• Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]
  od: Carey, Paul D, i dr.
  Izdano: (2005)
• Topiramate augmentation in a patient with obsessive–compulsive disorder
  od: Van Ameringen, Michael, i dr.
  Izdano: (2015)
• Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot placebo-controlled trial
  od: Pittenger, Christopher, i dr.
  Izdano: (2015)
• Buprenorphine augmentation in the treatment of refractory obsessive–compulsive disorder
  od: Liddell, Malcolm B., i dr.
  Izdano: (2013)
• N-Acetylcysteine augmentation in refractory obsessive–compulsive disorder
  od: Bhaskara, Sreenivasa
  Izdano: (2019)